Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1200038	注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白		Lyophilized	Biological Products(15)	New Drug Application	2012-08-16	苏州金盟生物技术有限公司	Suzhou Genemen Biotech Co Ltd	Certificate Issued	2015-01-15	view
CXSS1700023	注射用特立帕肽	teriparatide	Lyophilized	Biological Products(7)	New Drug Application	2017-11-15	苏州金盟生物技术有限公司	Suzhou Genemen Biotech Co Ltd	Certificate Issued	2019-10-16	view
CXSS2100011	特立帕肽注射液	teriparatide	Injection	Biological Products(3.3)	New Drug Application	2021-01-19	信立泰（苏州）药业有限公司	Suzhou Genemen Biotech Co Ltd	In Review	2021-01-19	view
CXSL2000065	特立帕肽注射液	teriparatide	Injection	Biological Products(15)	New Drug Application	2020-04-10	信立泰（苏州）药业有限公司	Suzhou Genemen Biotech Co Ltd	In Review	2020-04-09	view
CXSS2400061	注射用特立帕肽	teriparatide	Lyophilized	Biological Products(3.4)	New Drug Application	2024-06-25		Suzhou Genemen Biotech Co Ltd			view